journal article·2023-05-31

A Glucose Metabolic Intervention Nanoplatform for Enhanced Chemodynamic Therapy and Sensitized Photothermal Therapy of Hepatocellular Carcinoma

Lu Zhang, Hongwei Tian, Ying Guo, Shuo Yu, Jin Sun, Hong Wang, Yang Zhao, Xi Chen, Huan Shen, Jing Geng, Guangyao Kong, Fu Wang, Zongfang Li

ACS Applied Materials & Interfaces· Volume 15· Issue 21
Publisher page

Abstract

Traditional treatments for hepatocellular carcinoma (HCC) still lack effectiveness. Recently, the combined mode of chemodynamic therapy (CDT) and photothermal therapy (PTT) has shown great potential against HCC. However, insufficient Fenton reaction rates and hyperthermia-induced heat shock responses greatly impair their efficiency, hindering their further clinical application. Here, we constructed a cascade-amplified PTT/CDT nanoplatform by coating an IR780-embedded red blood cell membrane on glucose oxidase (GOx)-loaded Fe 3 O 4 nanoparticles for effective HCC treatment. On the one hand, the nanoplatform interfered with glucose metabolism through the action of GOx to reduce the synthesis of ATP, which reduced the expression of heat shock proteins, thereby sensitizing the IR780-mediated PTT. On the other hand, hydrogen peroxide generated during GOx catalysis and the thermal effect of PTT accelerated the Fe 3 O 4 -mediated Fenton reaction, realizing enhanced CDT. Consequently, the sensitized PTT and enhanced CDT for HCC management could be simultaneously achieved by interfering with glucose metabolism, providing an alternative strategy for the effective treatment of tumors.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Hepatocellular Carcinoma Treatment and Prognosis · Cancer, Hypoxia, and Metabolism

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

National and Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital, Xi’an Jiaotong University, Xi’an 710000, China

Institute of Cancer and Immunology, The Second Affiliated Hospital, Xi’an Jiaotong University, Xi’an 710000, P. R. China

Shaanxi Provincial Clinical Medical Research Center for Liver and Spleen Diseases, The Second Affiliated Hospital, Xi’an Jiaotong University, Xi’an 710000, P. R. China

Department of General Surgery, The Second Affiliated Hospital, Xi’an Jiaotong University, Xi’an 710000, China

Key Laboratory of Environment and Genes Related to Diseases, Ministry of Education, Xi’an Jiaotong University, Xi’an 710000, P. R. China

Funding

Xi?an Jiaotong University · National Natural Science Foundation of China · Natural Science Foundation of Shaanxi Province

References (59)

Show source-provided references
1. E.A.F.T.S.O.T., Liver · J. Hepatol. · 2018 · 69 · 18210.1016/j.jhep.2018.03.019 ↗
2. 10.1016/S0140-6736(18)30010-210.1016/S0140-6736(18)30010-2 ↗
3. 10.1053/j.gastro.2015.12.04110.1053/j.gastro.2015.12.041 ↗
4. 10.3322/caac.2160910.3322/caac.21609 ↗
5. 10.1002/hep.2774510.1002/hep.27745 ↗
6. 10.1016/j.ebiom.2019.02.01710.1016/j.ebiom.2019.02.017 ↗
7. 10.1016/j.canlet.2020.09.02410.1016/j.canlet.2020.09.024 ↗
8. 10.1016/j.nantod.2022.10138210.1016/j.nantod.2022.101382 ↗
9. 10.3322/caac.2138710.3322/caac.21387 ↗
10. 10.1038/s41598-017-14897-610.1038/s41598-017-14897-6 ↗
11. 10.1186/s12951-022-01305-z10.1186/s12951-022-01305-z ↗
12. 10.3390/cancers1206166310.3390/cancers12061663 ↗
13. 10.1016/j.semcancer.2019.08.01610.1016/j.semcancer.2019.08.016 ↗
14. 10.1021/acs.nanolett.8b0317810.1021/acs.nanolett.8b03178 ↗
15. 10.1002/adhm.20210197110.1002/adhm.202101971 ↗
16. 10.1021/acsami.2c2014410.1021/acsami.2c20144 ↗
17. 10.1021/acsami.2c2257810.1021/acsami.2c22578 ↗
18. 10.1002/advs.20220123210.1002/advs.202201232 ↗
19. 10.24411/0042-8833-2020-1006110.24411/0042-8833-2020-10061 ↗
20. 10.3390/ijms1812262510.3390/ijms18122625 ↗
21. 10.1055/s-2005-92331410.1055/s-2005-923314 ↗
22. 10.1021/acsnano.1c0917110.1021/acsnano.1c09171 ↗
23. 10.1016/j.cej.2022.13731010.1016/j.cej.2022.137310 ↗
24. 10.1038/s41467-022-30306-710.1038/s41467-022-30306-7 ↗
25. 10.1002/anie.20220002510.1002/anie.202200025 ↗
26. 10.1021/acsami.2c2244810.1021/acsami.2c22448 ↗
27. 10.1002/admi.20210226310.1002/admi.202102263 ↗
28. 10.1016/j.cej.2022.13504610.1016/j.cej.2022.135046 ↗
29. 10.34133/research.006110.34133/research.0061 ↗
30. 10.1002/adma.20221087610.1002/adma.202210876 ↗
31. 10.1002/adma.20200854010.1002/adma.202008540 ↗
32. 10.1002/anie.20201537910.1002/anie.202015379 ↗
33. 10.1002/smll.20200151810.1002/smll.202001518 ↗
34. 10.2147/JHC.S35853910.2147/JHC.S358539 ↗
35. 10.1111/liv.1512910.1111/liv.15129 ↗
36. 10.1067/msy.2002.12754510.1067/msy.2002.127545 ↗
37. 10.1021/acsnano.9b0391010.1021/acsnano.9b03910 ↗
38. 10.1021/acsami.2c0347410.1021/acsami.2c03474 ↗
39. 10.1002/adfm.20220555010.1002/adfm.202205550 ↗
40. 10.1016/j.biomaterials.2022.12162110.1016/j.biomaterials.2022.121621 ↗
41. 10.1002/smll.20210252710.1002/smll.202102527 ↗
42. 10.1016/j.cej.2022.13629610.1016/j.cej.2022.136296 ↗
43. 10.1021/acsnano.2c0217710.1021/acsnano.2c02177 ↗
44. 10.1002/adfm.20190980610.1002/adfm.201909806 ↗
45. 10.1002/adhm.20210144910.1002/adhm.202101449 ↗
46. 10.1002/adfm.20210073810.1002/adfm.202100738 ↗
47. 10.1021/acsnano.6b0665810.1021/acsnano.6b06658 ↗
48. 10.1085/jgp.8.6.51910.1085/jgp.8.6.519 ↗
49. 10.1126/science.123.3191.30910.1126/science.123.3191.309 ↗
50. 10.1038/s41467-021-21841-w10.1038/s41467-021-21841-w ↗
51. 10.1038/s42255-020-0251-410.1038/s42255-020-0251-4 ↗
52. 10.1039/C7CS00891K10.1039/C7CS00891K ↗
53. 10.1002/adma.20180832510.1002/adma.201808325 ↗
54. 10.1016/j.scib.2019.12.02410.1016/j.scib.2019.12.024 ↗
55. 10.1002/adfm.20211185310.1002/adfm.202111853 ↗
56. 10.1021/jp045402y10.1021/jp045402y ↗
57. 10.1002/anie.20171299610.1002/anie.201712996 ↗
58. 10.7150/thno.3793010.7150/thno.37930 ↗
59. 10.1021/acsnano.7b0821910.1021/acsnano.7b08219 ↗